LF
Lewis-Hall Freda C
Director
BoardF
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Lewis-Hall Freda C, Director. Officer active across 7 companies, notably SpringWorks Therapeutics, Inc.. Aggregated, 17 reports have been logged. Activity tracked since 20 May 2021. The latest transaction was disclosed on 12 August 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Lewis-Hall Freda C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
35,000 shares0Common StockSEC:0001641172-25-025539:0
24,727 sharesCommon StockSEC:0001104659-25-065318:0
10,060 shares0Common StockSEC:0001104659-25-049661:0
47,612 shares@ US$0.8950.6% of flowCommon StockSEC:0001641172-25-002240:0
437,976 shares@ US$0.091949.4% of flowCommon StockSEC:0001493152-24-046993:0
4,095 shares0Common StockSEC:0001104659-24-062991:0
35,219 shares0Common StockSEC:0000950170-24-038103:0
3,599 shares0Common StockSEC:0001209191-23-036303:0
4,648 shares0Common StockSEC:0001104659-23-064647:0
139,355 shares0Common StockSEC:0001209191-23-021409:0
4,534 shares@ US$18.00100.0% of flowCommon StockSEC:0001562180-23-001850:0
5,606 shares0Common StockSEC:0001209191-22-036398:0
4,534 sharesCommon StockSEC:0001562180-22-004860:0
4,818 shares0Common StockSEC:0001104659-22-063505:0
66,831 shares0Common StockSEC:0001140361-22-012913:0
2,011 shares0Common StockSEC:0001209191-21-044866:0
1,106 shares0Common StockSEC:0001104659-21-070516:0
About Lewis-Hall Freda C
Lewis-Hall Freda C is Administrateur and a declarant in 17 filings in total. In the 17 sampled recent filings, the reported sell amount is EUR 76617, covering the period from 2021-05-21 to 2025-08-26, with a transaction nature of Attribution.